Class 514 drug, bio-affecting and body treating compositions | |
---|---|
uspc | description |
514/1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) |
514/1.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai |
514/1.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.2) transporter affecting or utilizing |
514/1.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.3) prodrug utilizing |
514/1.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.4) sepsis affecting |
514/1.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.5) respiratory distress syndrome (e.g., ards, irds, etc.) affecting |
514/1.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.6) pneumonia affecting |
514/1.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.7) asthma affecting |
514/1.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.8) cystic fibrosis affecting |
514/1.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.9) arteriosclerosis (e.g., atherosclerosis, etc.) affecting |
514/2.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.1) endotoxin (e.g., lps, etc.) affecting |
514/2.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.2) bactericidal/permeability-increasing (bpi) protein affecting or utilizing |
514/2.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting |
514/2.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting |
514/2.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.5) lactoferrin |
514/2.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.6) streptococcus |
514/2.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.7) staphylococcus (e.g., staphylococcus aureus, etc.) |
514/2.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.8) gram negative bacterium (e.g., escherichia coli, salmonella, helicobacter, etc.) |
514/2.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.9) cyclopeptide utilizing |
514/3.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (3.1) glycopeptide utilizing |
514/3.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (3.2) amphiphilic or oligomer modified peptide (e.g., magainin, peptide nucleic acid, or pegylated peptide, etc.) utilizing |
514/3.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.3) fungus (e.g., athlete's foot, ringworm, etc.) destroying or inhibiting |
514/3.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.3) fungus (e.g., athlete's foot, ringworm, etc.) destroying or inhibiting (3.4) candida (e.g., candida albicans, etc.) |
514/3.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.3) fungus (e.g., athlete's foot, ringworm, etc.) destroying or inhibiting (3.5) yeast |
514/3.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.3) fungus (e.g., athlete's foot, ringworm, etc.) destroying or inhibiting (3.6) cyclopeptide utilizing |
514/3.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting |
514/3.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (3.8) human immunodeficiency virus (hiv) |
514/3.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (3.8) human immunodeficiency virus (hiv) (3.9) cluster of differentiation protein (e.g., cd4, etc.) affecting |
514/4.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (3.8) human immunodeficiency virus (hiv) (4.1) hiv protease inhibitor affecting or utilizing |
514/4.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (4.2) herpesviridae |
514/4.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (4.3) hepatitis |
514/4.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (4.4) protozoa destroying or inhibiting |
514/4.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.5) insect destroying or inhibiting |
514/4.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.6) parasite (e.g., tapeworm, roundworm, nematode, etc.) destroying or inhibiting |
514/4.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.7) lactation affecting |
514/4.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting |
514/4.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting (4.9) appetite or satiation affecting |
514/5.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting (5.1) growth hormone (gh) or derivative utilizing |
514/5.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting (5.2) neuropeptide (e.g., npy, pyy, dynorphin, etc.) or derivative utilizing |
514/5.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting (5.3) peptide hormone or derivative utilizing |
514/5.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.4) iron affecting |
514/5.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.5) nutrition enhancement or support |
514/5.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.5) nutrition enhancement or support (5.6) containing whey |
514/5.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.5) nutrition enhancement or support (5.7) containing casein |
514/5.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.8) leptin or derivative affecting or utilizing |
514/5.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing |
514/6.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.1) truncated insulin |
514/6.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.2) a-chain modified insulin |
514/6.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.3) b-chain modified insulin |
514/6.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.4) zinc containing |
514/6.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.5) with an additional active ingredient |
514/6.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.5) with an additional active ingredient (6.6) with protamine |
514/6.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.7) insulin affecting |
514/6.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting |
514/6.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting (6.9) diabetes |
514/7.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting (6.9) diabetes (7.1) somatostatin or derivative affecting or utilizing |
514/7.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting (6.9) diabetes (7.2) glucagon, glucagon-like peptide (e.g., glp-1, etc.) or derivative affecting or utilizing |
514/7.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting (6.9) diabetes (7.3) type i diabetes |
514/7.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.4) lipid or cholesterol affecting (e.g., dyslipidemia, etc.) |
514/7.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.5) protein tyrosine kinase (ptk) affecting |
514/7.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing |
514/7.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (7.7) erythropoietin (epo) or derivative |
514/7.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (7.8) thrombopoietin (tpo) or derivative |
514/7.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (7.9) hematopoiesis affecting |
514/8.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.1) vascular endothelial growth factor (e.g., vegf-a, vegf-b, etc.) or derivative |
514/8.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.2) platelet-derived growth factor (pdgf) or derivative |
514/8.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.3) nerve tissue or nerve cell growth affecting |
514/8.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.3) nerve tissue or nerve cell growth affecting (8.4) nerve growth factor (ngf) or derivative |
514/8.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.5) insulin-like growth factor (igf) or derivative |
514/8.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.5) insulin-like growth factor (igf) or derivative (8.6) insulin-like growth factor 1 (igf-1) or derivative |
514/8.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.5) insulin-like growth factor (igf) or derivative (8.7) insulin-like growth factor binding protein (igfbp) or derivative |
514/8.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.8) bone morphogenic protein (bmp) or derivative |
514/8.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.9) transforming growth factor (tgf) or derivative |
514/9.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.1) fibroblast growth factor (fgf) or derivative |
514/9.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.1) fibroblast growth factor (fgf) or derivative (9.2) keratinocyte growth factor (kgf) or derivative |
514/9.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.3) fibronectin or derivative |
514/9.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.4) wound healing or wound repair affecting |
514/9.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.5) hepatocyte growth factor (hgf) or derivative |
514/9.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.6) epidermal growth factor (egf) or epidermal growth factor-like or derivative |
514/9.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing |
514/9.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility |
514/9.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (9.9) follicle-stimulating hormone (fsh) or derivative |
514/10.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.1) luteinizing hormone (lh) or derivative |
514/10.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.2) androgen (e.g., testosterone, etc.) or estrogen affecting |
514/10.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.3) gonadotropin-releasing hormone (gnrh) or derivative |
514/10.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.3) gonadotropin-releasing hormone (gnrh) or derivative (10.4) cetrorelix, leuprolide, or deslorelin utilizing |
514/10.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.3) gonadotropin-releasing hormone (gnrh) or derivative (10.5) ovulation affecting |
514/10.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.3) gonadotropin-releasing hormone (gnrh) or derivative (10.6) synthetic gonadotropin-releasing hormone antagonist |
514/10.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (10.7) melanocortin (e.g., melanocyte-stimulating hormone (msh), etc.) or derivative |
514/10.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (10.7) melanocortin (e.g., melanocyte-stimulating hormone (msh), etc.) or derivative (10.8) corticotropin or derivative |
514/10.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (10.9) vasopressin or derivative |
514/11.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.1) somatostatin or derivative |
514/11.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.2) growth-hormone-releasing hormone (ghrh) or derivative |
514/11.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.3) growth hormone (gh) or derivative |
514/11.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.3) growth hormone (gh) or derivative (11.4) human growth hormone (hgh) or derivative |
514/11.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.5) prolactin or derivative |
514/11.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.6) oxytocin or derivative |
514/11.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.7) glucagon, glucagon-like peptide (e.g., glp-1, glp-2, etc.) or derivative |
514/11.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.8) parathyroid hormone (pth) or derivative |
514/11.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.9) calcitonin or derivative |
514/12.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.1) muscle contraction affecting (e.g., muscle twitch, muscle relaxation, etc.) |
514/12.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.2) anti-inflammatory |
514/12.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.3) gastrin hormone or derivative |
514/12.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.4) natriuretic peptide or derivative (e.g., atrial natriuretic peptide, brain natriuretic peptide, etc.) |
514/12.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.5) bradykinin or derivative |
514/12.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.6) cholecystokinin (cck) or derivative |
514/12.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.7) relaxin or derivative |
514/12.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.8) secretin or derivative |
514/12.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.9) thymosin (e.g., thymosin (alpha 1, thymosin beta 4, etc.) or derivative |
514/13.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (13.1) vasoactive intestinal peptide (vip) or derivative |
514/13.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.2) digestive tract ulcer affecting |
514/13.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.3) angiogenesis affecting |
514/13.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.4) blood substitute |
514/13.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing |
514/13.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.6) fibrin or derivative affecting or utilizing |
514/13.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting |
514/13.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (13.8) platelet aggregation or adhesion affecting |
514/13.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (13.8) platelet aggregation or adhesion affecting (13.9) glycoprotein iib/iiia affecting |
514/14.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.1) factor viii or derivative affecting or utilizing |
514/14.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting |
514/14.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.3) factor viia affecting |
514/14.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.4) factor xa affecting |
514/14.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.4) factor xa affecting (14.5) tissue factor pathway inhibitor (tfpi) utilizing |
514/14.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.6) urokinase affecting |
514/14.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.7) thrombin affecting |
514/14.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.7) thrombin affecting (14.8) hirudin or derivative utilizing |
514/14.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.9) thrombosis affecting |
514/15.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (15.1) oxidative stress affecting |
514/15.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (15.2) albumin or derivative affecting or utilizing |
514/15.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (15.3) plasma protein affecting or utilizing |
514/15.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.4) kidney affecting |
514/15.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.5) surfactant protein (e.g., sp-a, sp-b, etc.) or derivative affecting or utilizing |
514/15.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting |
514/15.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension |
514/15.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension (15.8) renin inhibitor affecting or utilizing |
514/15.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension (15.8) renin inhibitor affecting or utilizing (15.9) dipeptide renin inhibitor |
514/16.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension (16.1) endothelin (e.g., et-2, et-3, etc.) or derivative affecting or utilizing |
514/16.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension (16.2) angiotensin converting enzyme (ace) affecting |
514/16.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.3) angiotensin converting enzyme (ace) affecting |
514/16.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.4) cardiac disease (i.e., heart disease) affecting |
514/16.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.5) tissue development affecting |
514/16.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.6) rheumatoid arthritis affecting |
514/16.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.7) bone affecting |
514/16.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.7) bone affecting (16.8) osteoarthritis |
514/16.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.7) bone affecting (16.9) osteoporosis |
514/17.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.1) cartilage affecting |
514/17.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.2) collagen or derivative affecting or utilizing |
514/17.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.3) n-methyl-d-aspartate (nmda) receptor affecting |
514/17.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.4) ion channel protein affecting |
514/17.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.5) mental disorder or mental illness (e.g., psychoses, etc.) affecting |
514/17.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.5) mental disorder or mental illness (e.g., psychoses, etc.) affecting (17.6) anti-depressant or derivative affecting or utilizing |
514/17.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting |
514/17.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (17.8) alzheimer's disease |
514/17.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (17.9) multiple sclerosis |
514/18.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.1) neurotransmitter or derivative affecting or utilizing |
514/18.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.2) neuropathy affecting |
514/18.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.3) pain affecting |
514/18.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.3) pain affecting (18.4) opioid receptor affecting |
514/18.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.3) pain affecting (18.5) enkephalin or derivative affecting or utilizing |
514/18.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (18.6) skin affecting |
514/18.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (18.6) skin affecting (18.7) anti-inflammatory |
514/18.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (18.6) skin affecting (18.8) cosmetic enhancement or care |
514/18.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (18.9) apoptosis affecting |
514/19.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.1) cellular adhesion affecting or cell adhesion molecule (cam) affecting or utilizing |
514/19.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting |
514/19.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer |
514/19.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.4) breast |
514/19.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.5) prostate |
514/19.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.6) leukemia |
514/19.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.7) bombesin or derivative affecting or utilizing |
514/19.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.8) metastasis affecting |
514/19.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.9) cyclopeptide utilizing |
514/20.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.1) protease inhibitor affecting or utilizing |
514/20.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.1) protease inhibitor affecting or utilizing (20.2) cysteine protease inhibitor affecting or utilizing |
514/20.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.1) protease inhibitor affecting or utilizing (20.3) serine protease inhibitor affecting or utilizing |
514/20.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.1) protease inhibitor affecting or utilizing (20.3) serine protease inhibitor affecting or utilizing (20.4) elastase inhibitor affecting or utilizing |
514/20.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.5) cyclosporine or derivative utilizing |
514/20.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.6) g-protein coupled receptor (gpcr) affecting |
514/20.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.7) hair affecting |
514/20.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.8) eye affecting |
514/20.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.9) glycopeptide utilizing |
514/21.1 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.1) cyclopeptide utilizing |
514/21.2 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.2) 100 or more amino acid residues in the peptide chain |
514/21.3 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.3) 25 to 99 amino acid residues in the peptide chain |
514/21.4 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.4) 16 to 24 amino acid residues in the peptide chain |
514/21.5 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.5) 12 to 15 amino acid residues in the peptide chain |
514/21.6 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.6) 9 to 11 amino acid residues in the peptide chain |
514/21.7 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.7) 7 or 8 amino acid residues in the peptide chain |
514/21.8 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.8) 5 or 6 amino acid residues in the peptide chain |
514/21.9 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.9) 3 or 4 amino acid residues in the peptide chain |
514/21.91 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.91) 2 amino acid residues in the peptide chain |
514/21.92 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.92) produced by or extracted from animal tissue |
514/22 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (22) lignin or derivative doai |
514/23 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai |
514/24 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (24) s-glycoside |
514/25 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside |
514/26 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (26) cyclopentanohydrophenanthrene ring system |
514/27 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring |
514/28 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring (28) the hetero ring has 8 or more ring carbons |
514/29 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring (28) the hetero ring has 8 or more ring carbons (29) the hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.) |
514/30 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring (28) the hetero ring has 8 or more ring carbons (30) the hetero ring has exactly 15 ring carbons |
514/31 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring (28) the hetero ring has 8 or more ring carbons (31) the hetero ring has 20 or more ring carbons (e.g., nystatin, etc.) |
514/32 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (32) oxygen of the saccharide radical bonded to a nonsaccharide hetero ring by acyclic carbon bonding |
514/33 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (33) oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings |
514/34 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (33) oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings (34) oxygen of the saccharide radical bonded directly to a polycyclo ring system of four carbocyclic rings (e.g., daunomycin, etc.) |
514/35 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring |
514/36 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring |
514/37 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (37) the nitrogen atoms are in n-c(=n)-n groups (e.g., streptomycin, etc.) |
514/38 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (38) two saccharide radicals bonded through only oxygen to adjacent ring carbons of the cyclohexyl ring |
514/39 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (38) two saccharide radicals bonded through only oxygen to adjacent ring carbons of the cyclohexyl ring (39) three or more saccharide radicals (e.g., neomycin, etc.) |
514/40 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (40) two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring |
514/41 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (40) two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring (41) kanamycin or derivative |
514/42 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside |
514/43 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring |
514/44R | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (44r) polynucleotide (e.g., rna, dna, etc.) |
514/44A | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (44r) polynucleotide (e.g., rna, dna, etc.) (44a) antisense or rna interference |
514/45 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (45) purines (including hydrogenated) (e.g., adenine, guanine, etc.) |
514/46 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (45) purines (including hydrogenated) (e.g., adenine, guanine, etc.) (46) adenosine or derivative |
514/47 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (45) purines (including hydrogenated) (e.g., adenine, guanine, etc.) (46) adenosine or derivative (47) phosphorus containing |
514/48 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (45) purines (including hydrogenated) (e.g., adenine, guanine, etc.) (48) phosphorus containing |
514/49 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (49) pyrimidines (including hydrogenated) (e.g., cytosine, etc.) |
514/50 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (49) pyrimidines (including hydrogenated) (e.g., cytosine, etc.) (50) 2,4-diketone pyrimidine or derivative (e.g., uracil, etc.) |
514/51 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (49) pyrimidines (including hydrogenated) (e.g., cytosine, etc.) (50) 2,4-diketone pyrimidine or derivative (e.g., uracil, etc.) (51) phosphorus containing |
514/52 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (52) phosphorus containing (e.g., vitamin b12, etc.) |
514/53 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (53) dissacharide |
514/54 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide |
514/55 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (55) chitin or derivative |
514/56 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (56) heparin or derivative |
514/57 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (57) cellulose or derivative |
514/58 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (58) dextrin or derivative |
514/59 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (59) dextran or derivative |
514/60 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (60) starch or derivative |
514/61 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (61) tri- or tetrasaccharide |
514/62 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (62) glucosamine or derivative |
514/63 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (63) silicon containing doai |
514/64 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (64) boron containing doai |
514/65 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai |
514/66 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (66) with heterocyclic compound |
514/67 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (66) with heterocyclic compound (67) methylenedioxyphenyl group containing (e.g., piperonyl butoxide, etc.) |
514/68 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (68) with carboxylic acid ester |
514/69 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (69) with carboxylic acid metal salt |
514/70 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (70) with organic nitrogen containing compound |
514/71 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (70) with organic nitrogen containing compound (71) sulfur containing organic nitrogen compound |
514/72 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (72) with organic oxygen containing compound |
514/73 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (72) with organic oxygen containing compound (73) phosphorus or halogen containing organic oxygen compound |
514/74 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (74) with hydrocarbon or halohydrocarbon |
514/75 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (75) phosphorus containing other than solely as part of an inorganic ion in an addition salt doai |
514/76 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (75) phosphorus containing other than solely as part of an inorganic ion in an addition salt doai (76) amine addition salt of organic phosphorus containing acid |
514/77 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (75) phosphorus containing other than solely as part of an inorganic ion in an addition salt doai (77) inner salt (e.g., betaine, etc.) |
514/78 | 514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (75) phosphorus containing other than solely as part of an inorganic ion in an addition salt doai (77) inner salt (e.g., betaine, etc.) (78) lecithins |
Back to the Class List